Integra LifeSciences Holdings Net Income
| IART Stock | USD 11.99 0.55 4.81% |
As of the 18th of February 2026, Integra LifeSciences retains the Standard Deviation of 2.81, risk adjusted performance of (0.01), and Market Risk Adjusted Performance of (0.03). Integra LifeSciences technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Integra LifeSciences Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.5943 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -8 M | -7.6 M | |
| Net Income Applicable To Common Shares | 207.6 M | 218 M | |
| Net Loss | -8 M | -7.6 M | |
| Net Loss | (0.08) | (0.08) | |
| Net Income Per E B T | 0.34 | 0.33 |
Integra | Net Income | Build AI portfolio with Integra Stock |
The evolution of Net Income for Integra LifeSciences Holdings provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Integra LifeSciences compares to historical norms and industry peers.
Latest Integra LifeSciences' Net Income Growth Pattern
Below is the plot of the Net Income of Integra LifeSciences Holdings over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Integra LifeSciences financial statement analysis. It represents the amount of money remaining after all of Integra LifeSciences Holdings operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Integra LifeSciences' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Integra LifeSciences' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (6.94 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Integra Net Income Regression Statistics
| Arithmetic Mean | 49,197,181 | |
| Geometric Mean | 33,880,503 | |
| Coefficient Of Variation | 127.83 | |
| Mean Deviation | 47,998,771 | |
| Median | 41,204,000 | |
| Standard Deviation | 62,886,545 | |
| Sample Variance | 3954.7T | |
| Range | 205.9M | |
| R-Value | 0.24 | |
| Mean Square Error | 3969.8T | |
| R-Squared | 0.06 | |
| Significance | 0.35 | |
| Slope | 3,023,209 | |
| Total Sum of Squares | 63275.5T |
Integra Net Income History
Other Fundumenentals of Integra LifeSciences
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Integra LifeSciences Net Income component correlations
Integra Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Integra LifeSciences is extremely important. It helps to project a fair market value of Integra Stock properly, considering its historical fundamentals such as Net Income. Since Integra LifeSciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Integra LifeSciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Integra LifeSciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Health Care Equipment & Supplies market expansion? Will Integra introduce new products? Factors like these will boost the valuation of Integra LifeSciences. Market participants price Integra higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Integra LifeSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.004 | Earnings Share (6.47) | Revenue Per Share | Quarterly Revenue Growth 0.056 | Return On Assets |
Understanding Integra LifeSciences requires distinguishing between market price and book value, where the latter reflects Integra's accounting equity. The concept of intrinsic value - what Integra LifeSciences' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push Integra LifeSciences' price substantially above or below its fundamental value.
Please note, there is a significant difference between Integra LifeSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Integra LifeSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Integra LifeSciences' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Integra LifeSciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Integra LifeSciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Integra LifeSciences.
| 11/20/2025 |
| 02/18/2026 |
If you would invest 0.00 in Integra LifeSciences on November 20, 2025 and sell it all today you would earn a total of 0.00 from holding Integra LifeSciences Holdings or generate 0.0% return on investment in Integra LifeSciences over 90 days. Integra LifeSciences is related to or competes with Tandem Diabetes, Pacific Biosciences, Maravai Lifesciences, Septerna Common, Fortrea Holdings, Myriad Genetics, and Bicara Therapeutics. Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments ... More
Integra LifeSciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Integra LifeSciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Integra LifeSciences Holdings upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.05) | |||
| Maximum Drawdown | 15.12 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 4.72 |
Integra LifeSciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Integra LifeSciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Integra LifeSciences' standard deviation. In reality, there are many statistical measures that can use Integra LifeSciences historical prices to predict the future Integra LifeSciences' volatility.| Risk Adjusted Performance | (0.01) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.04) |
Integra LifeSciences February 18, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.01) | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 2.14 | |||
| Coefficient Of Variation | (3,744) | |||
| Standard Deviation | 2.81 | |||
| Variance | 7.89 | |||
| Information Ratio | (0.05) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 15.12 | |||
| Value At Risk | (3.49) | |||
| Potential Upside | 4.72 | |||
| Skewness | 0.6796 | |||
| Kurtosis | 0.7475 |
Integra LifeSciences Backtested Returns
Currently, Integra LifeSciences Holdings is not too volatile. Integra LifeSciences holds Efficiency (Sharpe) Ratio of 0.0606, which attests that the entity had a 0.0606 % return per unit of risk over the last 3 months. We have found twenty-three technical indicators for Integra LifeSciences, which you can use to evaluate the volatility of the firm. Please check out Integra LifeSciences' Standard Deviation of 2.81, risk adjusted performance of (0.01), and Market Risk Adjusted Performance of (0.03) to validate if the risk estimate we provide is consistent with the expected return of 0.18%. Integra LifeSciences has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.99, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Integra LifeSciences will likely underperform. Integra LifeSciences right now retains a risk of 2.94%. Please check out Integra LifeSciences maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Integra LifeSciences will be following its current trending patterns.
Auto-correlation | 0.06 |
Virtually no predictability
Integra LifeSciences Holdings has virtually no predictability. Overlapping area represents the amount of predictability between Integra LifeSciences time series from 20th of November 2025 to 4th of January 2026 and 4th of January 2026 to 18th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Integra LifeSciences price movement. The serial correlation of 0.06 indicates that barely 6.0% of current Integra LifeSciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.06 | |
| Spearman Rank Test | 0.44 | |
| Residual Average | 0.0 | |
| Price Variance | 0.81 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Integra Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Integra LifeSciences Holdings reported net income of (6.94 Million). This is 102.03% lower than that of the Health Care Equipment & Supplies sector and 102.92% lower than that of the Health Care industry. The net income for all United States stocks is 101.22% higher than that of the company.
Integra Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Integra LifeSciences' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Integra LifeSciences could also be used in its relative valuation, which is a method of valuing Integra LifeSciences by comparing valuation metrics of similar companies.Integra LifeSciences is currently under evaluation in net income category among its peers.
Integra LifeSciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Integra LifeSciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Integra LifeSciences' managers, analysts, and investors.Environmental | Governance | Social |
Integra LifeSciences Institutional Holders
Institutional Holdings refers to the ownership stake in Integra LifeSciences that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Integra LifeSciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Integra LifeSciences' value.| Shares | Soleus Capital Management, L.p. | 2025-06-30 | 1.4 M | Wellington Management Company Llp | 2025-06-30 | 1.3 M | Charles Schwab Investment Management Inc | 2025-06-30 | 1.2 M | Assenagon Asset Management Sa | 2025-06-30 | 1.2 M | Systematic Financial Management Lp | 2025-06-30 | 1.1 M | Neuberger Berman Group Llc | 2025-06-30 | 858.6 K | Millennium Management Llc | 2025-06-30 | 836.8 K | Deerfield Management Co | 2025-06-30 | 794.9 K | Voloridge Investment Management, Llc | 2025-06-30 | 749.8 K | Blackrock Inc | 2025-06-30 | 10.4 M | Vanguard Group Inc | 2025-06-30 | 7.6 M |
Integra Fundamentals
| Return On Equity | -0.39 | ||||
| Return On Asset | 0.0261 | ||||
| Profit Margin | (0.30) % | ||||
| Operating Margin | 0.1 % | ||||
| Current Valuation | 2.62 B | ||||
| Shares Outstanding | 77.89 M | ||||
| Shares Owned By Insiders | 13.95 % | ||||
| Shares Owned By Institutions | 96.53 % | ||||
| Number Of Shares Shorted | 7.63 M | ||||
| Price To Earning | 26.94 X | ||||
| Price To Book | 0.85 X | ||||
| Price To Sales | 0.54 X | ||||
| Revenue | 1.61 B | ||||
| Gross Profit | 944.73 M | ||||
| EBITDA | 193.29 M | ||||
| Net Income | (6.94 M) | ||||
| Cash And Equivalents | 451.52 M | ||||
| Cash Per Share | 5.41 X | ||||
| Total Debt | 1.98 B | ||||
| Debt To Equity | 1.03 % | ||||
| Current Ratio | 3.85 X | ||||
| Book Value Per Share | 13.33 X | ||||
| Cash Flow From Operations | 129.38 M | ||||
| Short Ratio | 11.24 X | ||||
| Earnings Per Share | (6.47) X | ||||
| Price To Earnings To Growth | 0.71 X | ||||
| Target Price | 15.5 | ||||
| Number Of Employees | 4.4 K | ||||
| Beta | 1.03 | ||||
| Market Capitalization | 881.95 M | ||||
| Total Asset | 4.04 B | ||||
| Retained Earnings | 939.91 M | ||||
| Working Capital | 159.56 M | ||||
| Current Asset | 438.5 M | ||||
| Current Liabilities | 139.13 M | ||||
| Net Asset | 4.04 B |
About Integra LifeSciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Integra LifeSciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Integra LifeSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Integra LifeSciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integra Stock Analysis
When running Integra LifeSciences' price analysis, check to measure Integra LifeSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integra LifeSciences is operating at the current time. Most of Integra LifeSciences' value examination focuses on studying past and present price action to predict the probability of Integra LifeSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integra LifeSciences' price. Additionally, you may evaluate how the addition of Integra LifeSciences to your portfolios can decrease your overall portfolio volatility.